Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

166.61 +3.00 (+1.83%)

Streaming Delayed Price Updated: 9:34 AM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

GeneDx to Participate in Upcoming Investor Conferences

May 22, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

May 16, 2024

Via Benzinga

Gold Down Over 2%; 3M Profit Beats Expectations ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 30, 2024

Via Benzinga

Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday ↗

April 30, 2024

Via Benzinga

Earnings Preview: GeneDx Hldgs ↗

February 19, 2024

Via Benzinga

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 30, 2024

Via Benzinga

Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 30, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 30, 2024

Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today!

Via InvestorPlace

WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024 ↗

April 29, 2024

WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance ↗

April 29, 2024

GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 29, 2024

Via Benzinga

GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

April 29, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

April 23, 2024

The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine

From GeneDx Holdings Corp.

Via GlobeNewswire

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

April 04, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 19, 2024

Via Benzinga

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

March 14, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 18, 2024

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 08, 2024

Via Benzinga

GeneDx to Participate in 44th Annual Cowen Health Care Conference

February 26, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 22, 2024

Via Benzinga

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

February 20, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024

February 01, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 25, 2024

Via Benzinga

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 24, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 10, 2024

Via Benzinga

GeneDx Announces Preliminary 2023 Financial Results

January 08, 2024

From GeneDx Holdings Corp.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.